PTGS2 and hepatocellular carcinoma: This internalization further activates the Toll-Like Receptor 4 (TLR4)/Toll-Like Receptor 9 (TLR9)–Cyclooxygenase-2 (COX2) signaling axis, which ultimately contributes to the malignant characteristics of HCC [43].